WHAT WE WANT TO BE
Ewopharma is the innovative partner for the marketing of pharmaceuticals and consumer health products in Switzerland and Central Eastern Europe. “We are ensuring our success as an independent, owner managed company by systematically expanding our specialty pharma and consumer health business. We are also strengthening our hospital business in the interest of diversification and increasing returns.” Alain Staub, President of the Board of Directors and CEO
Inosine Acedoben Dimepranol (IAD)
Inosine Acedoben Dimepranol (IAD) is the lead product of Newport Pharmaceuticals Ltd.
Newport's strategic operations In Ireland and access to the Central Eastern European Markets means we are looking for new niche pharmaceutical & Consumer Health business opportunities.
Newport Pharmaceuticals Limited has been established in Dublin, Ireland for more than 30 years.
News & Media
Mead Johnson Nutrition And Ewopharma Launch Nutramigen Puramino In The Czech Republic And Slovakia
Nijmegen, 23 January, 2017: Mead Johnson Nutrition announces that it...Read More
Ewopharma Strengthens Its Oncology Business
Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and...Read More
Shield Therapeutics And Ewopharma Sign Feraccru Licence Agreement For Switzerland
London, UK, 6th July 2017: Shield Therapeutics plc (LSE:STX), a...Read More